| Trinex Minerals Limited (TX3) ORDINARY FULLY PAID |
Materials |
$8 |
Notice of General Meeting/Proxy Form
|
15 Aug 2025 8:20AM |
$0.125 |
$0.180 |
risen by
44%
|
|
| Asian Battery Metals plc (AZ9) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$12 |
Flagship Cu-Ni-PGE Project Expanded
|
15 Aug 2025 8:20AM |
$0.039 |
$0.021 |
fallen by
46.15%
|
|
AZ9 - Price-sensitive ASX Announcement
Full Release
Key Points
- Asian Battery Metals plc expands AZ9 Cu-Ni-PGE project to 391 km² in Western Australia.
- Acquisition of an additional 274 km² of prospective land adjacent to existing holdings.
- Expansion driven by positive exploration results confirming widespread mineralization.
- AZ9 project is located in a prominent mining region with existing infrastructure.
- Project has strong potential for large-scale copper, nickel, and PGE deposits.
- Company plans to accelerate exploration and development activities in the expanded area.
- Expansion aligns with the company's strategy to focus on high-value battery metal projects.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| ANZ Group Holdings Limited (ANZ) ORDINARY FULLY PAID |
Financials |
$108,210 |
Pillar 3 / 3Q25 Chart Pack
|
15 Aug 2025 8:07AM |
$32.500 |
$35.900 |
risen by
10.46%
|
|
| ANZ Group Holdings Limited (ANZ) ORDINARY FULLY PAID |
Financials |
$108,210 |
APS 330 Pillar 3 Disclosure at 30 June 2025
|
15 Aug 2025 8:02AM |
$32.500 |
$35.900 |
risen by
10.46%
|
|
| Move Logistics Group Limited (MOV) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Industrials |
$19 |
Director Nomination Closing Date
|
15 Aug 2025 7:34AM |
$0.215 |
$0.150 |
fallen by
30.23%
|
|
| Cochlear Limited (COH) ORDINARY FULLY PAID |
Health Care |
$6,609 |
Application for quotation of securities - COH
|
15 Aug 2025 7:33AM |
$305.990 |
$101.060 |
fallen by
66.97%
|
|
| Cochlear Limited (COH) ORDINARY FULLY PAID |
Health Care |
$6,609 |
Application for quotation of securities - COH
|
15 Aug 2025 7:33AM |
$305.990 |
$101.060 |
fallen by
66.97%
|
|
| Cochlear Limited (COH) ORDINARY FULLY PAID |
Health Care |
$6,609 |
Update - Notification of buy-back - COH
|
15 Aug 2025 7:33AM |
$305.990 |
$101.060 |
fallen by
66.97%
|
|
COH - Price-sensitive ASX Announcement
Full Release
Key Points
- Cochlear Limited is conducting an on-market buy-back of fully paid ordinary shares.
- The buy-back was initially announced on 15th August 2024 and has been extended to 28th August 2026.
- The company plans to buy back up to $75 million of its fully paid ordinary shares.
- WealthHub Securities Limited will act as the broker for this buy-back.
- The buy-back does not require security holder approval.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cochlear Limited (COH) ORDINARY FULLY PAID |
Health Care |
$6,609 |
Update - Notification of buy-back - COH
|
15 Aug 2025 7:33AM |
$305.990 |
$101.060 |
fallen by
66.97%
|
|
COH - Price-sensitive ASX Announcement
Full Release
Key Points
- Cochlear Limited extended on-market buy-back program.
- Buy-back extension from 15/8/2024 to 28/8/2026.
- Buy-back allows repurchase of up to $75 million of shares.
- Facilitated by WealthHub Securities Limited.
- Buy-back conducted in AUD.
- No security holder approval required.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| EROAD Limited (ERD) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Information Technology |
$155 |
Disclosure of ceasing to have substantial holding
|
15 Aug 2025 7:32AM |
$2.130 |
$0.825 |
fallen by
61.27%
|
|
| Metro Performance Glass Limited (MPP) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Industrials |
$20 |
Director Nominations closing date and ASM date
|
15 Aug 2025 7:32AM |
$0.040 |
$0.820 |
risen by
1,950%
|
|
| Auckland International Airport Limited (AIA) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Industrials |
$11,509 |
July 2025 Monthly traffic update
|
15 Aug 2025 7:32AM |
$6.980 |
$6.770 |
fallen by
3.01%
|
|
| Meridian Energy Limited (MEZ) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Utilities |
$6,152 |
Meridian Energy monthly operating report for July 2025
|
15 Aug 2025 7:31AM |
$5.120 |
$4.670 |
fallen by
8.79%
|
|
MEZ - Price-sensitive ASX Announcement
Full Release
Key Points
- National hydro storage decreased from 104% to 87% of historical average by August 11, 2025.
- South Island storage decreased to 79% and North Island storage decreased to 119% of average.
- Meridian's July 2025 inflows were 89% of historical average.
- Retail sales volumes in July 2025 were 9.4% higher than July 2024.
- Residential sales were 15.9% higher and small medium business sales were 8.6% higher than July 2024.
- The average generation price received in July 2025 was 71.4% lower compared to the previous year.
- Total generation volume was 1,157 GWh, with hydro at 1,022 GWh and wind at 135 GWh.
- The cost to supply retail customers was $113.3/MWh.
- Meridian's customer connections increased by 1.4% during July 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cochlear Limited (COH) ORDINARY FULLY PAID |
Health Care |
$6,609 |
Appendix 4G
|
15 Aug 2025 7:31AM |
$305.990 |
$101.060 |
fallen by
66.97%
|
|
| Cochlear Limited (COH) ORDINARY FULLY PAID |
Health Care |
$6,609 |
2025 Tax Contribution Report
|
15 Aug 2025 7:31AM |
$305.990 |
$101.060 |
fallen by
66.97%
|
|
| Cochlear Limited (COH) ORDINARY FULLY PAID |
Health Care |
$6,609 |
FY25 Result - Presentation
|
15 Aug 2025 7:31AM |
$305.990 |
$101.060 |
fallen by
66.97%
|
|
COH - Price-sensitive ASX Announcement
Full Release
Key Points
- Sales revenue increased by 4% to $2,356 million, with cochlear implant revenue growing by 9%.
- Underlying net profit grew by 1% to $392 million, while statutory net profit increased by 9% to $389 million.
- The gross margin was 74%, slightly below the long-term target.
- The company maintained a strong financial position with net cash of $276 million.
- FY26 guidance projects an underlying net profit increase of 11-17%, with strong revenue growth expected in developed markets.
- Cochlear implants accounted for 62% of sales revenue, with units increasing by 12% to 53,968.
- The commencement of pivotal studies for drug eluting electrodes, aimed at improving hearing outcomes, was announced.
- Environmental responsibility efforts included using 97% renewable energy at manufacturing facilities and reducing Scope 1 and 2 emissions by 71% from the FY19 baseline.
- Cochlear Limited focuses on building a stronger organization through employee engagement, leadership development, and new technology investments.
- FY25 results reflect sustained value with a record sales revenue despite a slight drop in the gross margin due to market shifts.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cochlear Limited (COH) ORDINARY FULLY PAID |
Health Care |
$6,609 |
FY25 Result - ASX & Media Release
|
15 Aug 2025 7:31AM |
$305.990 |
$101.060 |
fallen by
66.97%
|
|
COH - Price-sensitive ASX Announcement
Full Release
Key Points
- Sales revenue increased 4% to $2,355.8 million.
- Underlying net profit rose by 1% to $391.6 million.
- Statutory net profit increased by 9% to $388.9 million.
- Cochlear Nucleus Nexa System launched with upgradable firmware.
- Dividend increased 5% to $4.30 per share, 72% payout of underlying net profit.
- FY26 underlying net profit guidance is $435-460 million.
- Continued investment in R&D and market growth activities.
- Services revenue declined, while cochlear and acoustic implants saw strong growth.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cochlear Limited (COH) ORDINARY FULLY PAID |
Health Care |
$6,609 |
FY25 Result - ASX & Media Release
|
15 Aug 2025 7:31AM |
$305.990 |
$101.060 |
fallen by
66.97%
|
|
COH - Price-sensitive ASX Announcement
Full Release
Key Points
- Sales revenue increased by 4% to $2,356 million.
- Statutory net profit rose 9% to $388.9 million.
- Underlying net profit increased 1% to $391.6 million.
- Launch of the Cochlearâ„¢ Nucleus® Nexaâ„¢ System.
- R&D investment reached $292 million, 12% of sales.
- Final dividend of $2.15 per share, total dividends $4.30.
- Nucleus Nexa System is the first smart cochlear implant with upgradeable firmware.
- Capital expenditure for FY26 expected to be $100-120 million.
- Strong cochlear implant growth, decline in Services revenue.
- Maintained over 60% global market share.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cochlear Limited (COH) ORDINARY FULLY PAID |
Health Care |
$6,609 |
Dividend/Distribution - COH
|
15 Aug 2025 7:31AM |
$305.990 |
$101.060 |
fallen by
66.97%
|
|
| Cochlear Limited (COH) ORDINARY FULLY PAID |
Health Care |
$6,609 |
Annual Report (incl Sustainability reporting)
|
15 Aug 2025 7:30AM |
$305.990 |
$101.060 |
fallen by
66.97%
|
|
| Cochlear Limited (COH) ORDINARY FULLY PAID |
Health Care |
$6,609 |
Appendix 4E
|
15 Aug 2025 7:30AM |
$305.990 |
$101.060 |
fallen by
66.97%
|
|
COH - Price-sensitive ASX Announcement
Full Release
Key Points
- Sales revenue increased by 4% to A$2,355.8 million.
- Total revenue increased by 5% to A$2,343.1 million.
- EBIT increased by 9% to A$517.8 million.
- Net profit attributable to shareholders increased by 9% to A$388.9 million.
- Underlying net profit increased by 1% to A$391.6 million.
- Basic earnings per share increased by 9% to 594.3 cents.
- Underlying basic earnings per share increased by 1% to 598.4 cents.
- Dividend per share increased by 5% to $4.30.
- Net tangible assets per share increased by 4% to 2,216.5 cents.
- No dividend reinvestment plans were in operation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cochlear Limited (COH) ORDINARY FULLY PAID |
Health Care |
$6,609 |
Appendix 4E
|
15 Aug 2025 7:30AM |
$305.990 |
$101.060 |
fallen by
66.97%
|
|
COH - Price-sensitive ASX Announcement
Full Release
Key Points
- Sales revenue increased by 4% to A$2,355.8 million.
- Total revenue increased by 5% to A$2,343.1 million.
- Earnings before interest and taxes (EBIT) rose by 9% to A$517.8 million.
- Net profit attributable to shareholders grew by 9% to A$388.9 million.
- Underlying net profit increased by 1% to A$391.6 million.
- Basic earnings per share increased by 9% to 594.3 cents.
- Underlying basic earnings per share rose by 1% to 598.4 cents.
- Dividend increased by 5% to A$4.30 per share.
- Net tangible assets per share were up 4% to 2,216.5 cents.
- Final dividend per share declared at A$2.15, with a payment date of 13 October 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| HealthCo Healthcare and Wellness REIT (HCW) ORDINARY UNITS FULLY PAID |
Real Estate |
$374 |
Appendix 4G and Corporate Governance Statement
|
15 Aug 2025 7:30AM |
$0.820 |
$0.680 |
fallen by
17.07%
|
|
| HealthCo Healthcare and Wellness REIT (HCW) ORDINARY UNITS FULLY PAID |
Real Estate |
$374 |
FY25 Results Presentation
|
15 Aug 2025 7:30AM |
$0.820 |
$0.680 |
fallen by
17.07%
|
|
| HealthCo Healthcare and Wellness REIT (HCW) ORDINARY UNITS FULLY PAID |
Real Estate |
$374 |
FY25 Results Announcement
|
15 Aug 2025 7:30AM |
$0.820 |
$0.680 |
fallen by
17.07%
|
|